Dr. Robert S. Epstein joined Medco in 1995 and has served as Medco's Chief Medical Officer since 1997. In this capacity, he is responsible for formulary development, clinical guidelines, drug information services, accreditation oversight, and personalized medicine services. He is also responsible for analysis and reporting for Medco's clients. In 2009, Dr. Epstein was named President of the Medco Research Institute, where he oversees Medco's peer-reviewed research initiatives and collaborations in the areas of personalized medicine, comparative effectiveness and chronic conditions.
Dr. Epstein was trained as an epidemiologist, and worked in public health and academia before joining the private sector. He is the past President of the International Society of Pharmacoeconomics and Outcomes Research, and has served on the Board of Directors for the Drug Information Association. In 2008, Dr. Epstein was nominated and elected to the Federal CDC EGAPP (Evaluation of Genomic Applications in Practice & Prevention) Stakeholder Committee, and the AHRQ CERT (Centers for Education and Research on Therapeutics) Committee. He has published more than 50 peer-reviewed medical articles and book chapters, and serves as a reviewer for several influential medical journals.